The traditional signs of general anaesthesia are obscured or absent when neuromuscular blocking drugs have been administered, and during total i.v. anaesthesia with the newer anaesthetic agents. A reliable technique to assess the depth of anaesthesia would be of great value under such circumstances and, if the technique could be used with all general anaesthetic agents, the anaesthetist could control the dose of anaesthetic agent more precisely and decrease the likelihood of awareness. The ideal technique would display a signal proportional to the depth of anaesthesia, show dose-related changes with all general anaesthetic agents, and be unaffected by neuromuscular blockade.
The traditional signs of general anaesthesia are obscured or absent when neuromuscular blocking drugs have been administered, and during total i.v. anaesthesia with the newer anaesthetic agents. A reliable technique to assess the depth of anaesthesia would be of great value under such circumstances and, if the technique could be used with all general anaesthetic agents, the anaesthetist could control the dose of anaesthetic agent more precisely and decrease the likelihood of awareness. The ideal technique would display a signal proportional to the depth of anaesthesia, show dose-related changes with all general anaesthetic agents, and be unaffected by neuromuscular blockade.
We have reported previously (Thornton et al., 1984) that components of the auditory evoked response show dose-related changes with the inhalation agents halothane and enflurane. These components, waves III, V, Pa and Nb, represent neural activity in the brain stem and primary cortical sections of the auditory pathway which has been initiated by a sound stimulus. They are not affected by myoneural blocking drugs.
If similar changes occur with other anaesthetic agents, it may be possible to use the auditory evoked response to assess depth of anaesthesia. In this paper we have examined the effects of the administration of etomidate i.v. The aims were to determine, first, whether etomidate had an effect on the auditory evoked response and, second, if this effect was doserelated. The entire study was carried out before SUMMARY The effect of etomidate on the auditory evoked response was examined in a double-blind study carried out before the start of surgery. Fourteen patients were anaesthetized with 70% nitrous oxide and oxygen after induction with thiopentone. Ventilation was controlled. Seven of the patients received a continuous infusion of etomidate, increasing in five equal steps from 0.01 mg kg' 1 min~1 to 0.05 mg kg' 1 min' 1 over a period of 50 min. The other seven received similarly an equivalent volume of saline. The patients given etomidate were easily distinguishable from those given saline, solely on the basis of changes in the early cortical peaks Pa and Nb. In the etomidate group the latencies of these peaks increased and their amplitudes decreased. These changes were linearly related to serum etomidate concentration. There was no effect of etomidate on the brainstem response.
surgery as we wished to avoid any possible effects of surgical stimulation on the response.
PATIENTS AND METHODS

Patients
Fourteen patients, aged 18-45 yr gave informed consent to an experimental programme approved by Harrow District Ethical Committee. The first 12 patients were randomly allocated in a double-blind manner to two groups. Five patients, the etomidate group, received an infusion of etomidate and the other seven, the saline group, received an equivalent volume of saline. Subsequently, a further two patients were added to the etomidate group to equalize the numbers.
Anaesthesia
After premedication with morphine 10 mg and atropine 600 ^g, anaesthesia was induced with thiopentone 2-4 mg kg" 1 i.v. The trachea was intubated after the administration of pancuronium 0.1 mg kg" 1 and the lungs were ventilated with 70% nitrous oxide in oxygen. An infusion i.v. of either etomidate* or saline was started 7 min after induction. In the etomidate group, the infusion was started with etomidate 0.01 mg kg" 1 min" 1 and increased in four equal increments to 0.05 mg kg" 1 min" 1 . Each infusion rate was maintained for 10 min. In the saline group, equivalent volumes of saline were infused over the same time period. In one patient in the etomidate group, the start of surgery was delayed, and so the infusion was discontinued, while artificial ventilation was maintained (with 70% nitrous oxide in oxygen).
Throughout the infusion and recovery periods, end-tidal carbon dioxide concentration (Godart 17070 infra-red analyser corrected for the effects of nitrous oxide) was kept constant to within 0.2 kPa of the starting value (range 4.5-5.5 kPa) by adjusting the minute volume. Body temperature was monitored using a thermistor in the oesophagus at the level of the aortic arch. Arterial pressure and heart rate were recorded at 5-10-min intervals.
Recording the auditory evoked response
The detailed technique has been described previously (Thornton et al., 1983) . In outline, binaural clicks of 75 dB intensity and 0.5 ms duration were presented through headphones at a rate of 6 per second. The EEG was recorded from silver-silver chloride disc electrodes at mastoid, inion and vertex with an FM tape recorder (RACAL 4).
The tapes were replayed through a DATALAB DL4000 to produce an average of the EEG for the 80 ms following 2048 clicks. This average, the auditory evoked response, took 5.7 min to record. Evoked responses were obtained before the induction of anaesthesia, and during the last part of the induction period and of each infusion period. In the patient in whom the infusion was discontinued after the highest concentration had been administered, averaged responses (following 1024 clicks) were taken throughout the recovery period. The latency and amplitude of waves I, III, V, Pa and Nb of each average were measured. *At the time of this study, etomidate was still available for use by continuous infusion.
Measurement of anaesthetic concentration
Venous blood samples were drawn from the arm opposite to that receiving the infusion at the end of the induction period, and in the 5th and 10th min of each infusion period. In the one patient whose recovery was monitored, a sample was taken at the end of this period.
Extraction of etomidate from serum for high pressure liquid chromatography (HPLC) was by a method described by Ellis and Beck (1982) using propoxate as internal standard. Samples were analysed subsequently by injecting 100 \il of extract to a 5-um ODS-Hypersil column (25 cm X 4.6 mm i.d.) with a mobile phase of 40% acetonitrile (HPLC Grade) and 60% ammonium acetate 0.2 mol litre" 1 at a flow of 1 ml min" 1 . Detection was at 248 nm: lower limit of detection 0.01 ug/ml serum.
Analysis of data
The electrophysiologist examined the traces for each patient in the blind study. Depending on whether or not there were consistent changes, patients were allocated to either "etomidate" or "saline" groups.
After the code had been broken, the data of the two extra etomidate patients were added to the etomidate group. Variables examined were the latencies and amplitudes of waves I, III, V, Pa, Nb and the interpeak intervals I-III, I-V, III-V. Satistical analyses were carried out to test for effects of etomidate on the auditory evoked response, and dose relationships of these effects.
To test for effects on the auditory evoked response. The etomidate and saline groups were compared by plotting each of the above variables for individual patients against time from the start of the first infusion. Parallel regression lines for each of the seven patients in the etomidate group were fitted using a computer program (MINITAB) (Ryan, Joiner and Ryan, 1976) . This assumes that variations in the slopes between the patients in the group were random. The same procedure was carried out for the saline group. The etomidate and saline slopes were compared using a t test to demonstrate any significant differences.
To see whether the effects were dose-related. The changes in the above variables with changing serum etomidate concentration were examined. As the averaged responses were recorded over the second half of each 10-min period, the mean of the serum concentration in the blood samples drawn in the 5th and 10th min was used as a basis for comparison.
Each variable was plotted against serum concentration for each patient in the etomidate group. A regression line representing the group was calculated and the significance of the slope was tested.
RESULTS
Double-blind study: early cortical response
When the code for the double-blind study was broken, it was found that the electrophysiologist had correctly identified all patients in the etomidate group. The difference between the two groups was easily seen and was confined to the early cortical response.
The effect of etomidate. Typical examples of the early cortical responses of two patients, one who received saline, and the other who received etomidate are shown in figure 1. There was an increase in latency, and decreases in the amplitude of waves Pa and Nb in the patient who received etomidate whereas no such changes were evident in the patient who received saline.
Statistical analyses of the data for the whole group confirmed these effects. The slopes of Pa and Nb latency and amplitude v. time in the etomidate group were significantly different from the corresponding slopes in the saline group (table I) .
Dose relationship of the effect. The changes in latency and amplitude in the etomidate patients were progressive with increasing serum concentration ( fig. 1) . Pa latency increased from 26 to 35 ms and Nb latency from 32 to 67 ms as the etomidate concentration was increased from 0.01 to 0.53 (xg ml" 1 . Once again, statistical analysis of the group data confirmed this relationship, in that the slopes relating Pa and Nb latency and amplitude to serum concentration were significant (table II) . The changes in latency and amplitude of Pa and Nb were related to the serum concentration of etomidate and not to time. This is illustrated in figure 2, in which the patient whose evoked responses are shown on the left had a serum concentration of 0.26 ug ml" 1 after 50 min, and the changes in Pa and Nb were very similar to those shown on the right, where the serum etomidate concentration was 0.29 (ig ml" 1 at only 20 min. The final serum etomidate concentration ranged from 0.32 to 1.72 jig ml" 1 for the group, despite the same infusion rates ( fig. 3 ). In one patient (P7), etomidate was not detected in serum until the fourth infusion rate had been started.
In this same patient, the infusion was discontinued once the highest concentration had been administered. The latencies continued to increase and the amplitude to decrease for 3 min, then the changes in the early cortical response began to reverse so that, 10 min after the discontinuation of the infusion, the early cortical response was almost identical in appearance to the post-induction recording. By this time the serum etomidate concentration had decreased to 0.06 ug ml" 1 ( fig. 4 ). FIG. 1. Averaged early cortical evoked responses of two patients, one who received a saline infusion (left) and the other who received saline with etomidate added (right). The traces represent the first, third and fifth infusion periods. The serum etomidate concentrations corresponding to these rates are given. Pa (V) and Nb (A) occur at approximately 26 and 37 ms in conscious patients.
Brainstem response
The effect of etomidate. The brainstem responses of the patients in the etomidate group were indistinguishable from those in the saline group. Figure 5 gives typical examples of the brainstem responses of two patients, one who received saline, the other who received etomidate. There is no essential difference between the two traces. Neither of these patients showed changes in the latency or amplitude of I, III orV. The slopes of the latencies and amplitudes of I, III and V and interpeak intervals I-III, I-V, III-V, v. time were not significantly different from the corresponding slopes in the saline group (table I) .
Dose relationship of the effect. The slopes of these variables against serum etomidate concentration were not significant, with the exceptions of the latency and amplitude of wave III, both of which increased with increasing concentration (table II) .
Body temperature, end-tidal carbon dioxide concentration and arterial pressure
There were no major changes in any of these variables. Table III gives the mean and SEM of the changes in end-tidal carbon dioxide concentration, arterial pressure and oesophageal temperature over the whole infusion period. Small decreases in body temperature (max 0.5 °C) did occur in some, but not .05 ns all, subjects. In both groups there were minimal changes in the end-tidal carbon dioxide concentration. Arterial pressure never decreased to less than 80 mm Hg systolic, although the mean decrease of 10 mm Hg in the test group was just significantly different (P = 0.05) from the mean increase which occurred in the control group. This mean change in the test group was also significantly different (P = 0.05) from those changes seen with halothane and enflurane in our previously reported study: -28 (5) mm Hg and -28 (3) mm Hg (mean (SEM)) respectively.
DISCUSSION
All patients who received etomidate, even when the drug status of the patients was not known, were easily distinguishable from controls solely on the basis of changes in the early cortical part of the auditory evoked response. Furthermore, the changes in the early cortical response were dose-related, in that the latency of Pa and Nb increased and their amplitude decreased linearly with increasing concentration. The effectvon wave amplitude and latency were related to drug concentration and not to time because: (l) the changes were not seen in the saline group, which had the same schedule but no etomidate;
(2) the changes were similar in patients with similar serum concentrations at different times; (3) the changes in Pa and Nb returned almost to preinfusion values when the infusion was discontinued following the highest concentration. At this time, 1 h following the start of the infusion, the serum concentration was virtually zero. Etomidate produced changes in the early cortical response which were similar to those observed with the inhalation agents halothane and enflurane (Thornton et al., 1984) (fig. 6 ). With these agents, the effects were also dose-related. Furthermore, all three agents produced changes of a similar magnitude over an approximately equipotent range etomidate (0-0.66 \ig ml" 1 equates with 0-1. halothane or 0-2.5% enflurane). (The plasma concentration of etomidate when patients are just reusable is 0.14-0.2 (xg ml" 1 (Doenicke et al., 1982; Schiittler, Schurlden and Stoekel, 1983) . If this is in the same ratio to the anaesthetizing concentration as "MAC awake" is to "MAC" for inhalation agents, that is 0.6 (Stoelting, Longnecker and Eger, 1970) , then we can calculate an "MAC equivalent" of etomidate of 0.2-0.3 jig/ml plasma concentration; "MAC" for halothane is 0.75; "MAC" for enflurane is 1.68 (Eger, 1974) .) The etomidate and saline groups could not be distinguished on the basis of any of the brainstem variables and we conclude that etomidate does not affect the brainstem response. Although there was no difference between the etomidate and saline groups when the latency and amplitude of wave III were plotted against time, these variables showed significant increases with etomidate concentration. These changes were small in magnitude (table II) . Furthermore, the slope of the interpeak interval from I to III against serum concentration had a value of 0.00 ms |xg"' ml" 1 , suggesting that the increase in the latency of wave III may have been the result of an increase in the latency of wave I. We would have expected the amplitude of wave III to decrease, if anything, with increasing etomidate concentration and, therefore, tend to dismiss these changes in wave III as chance findings.
Etomidate differs from halothane and enflurane in that the inhalation agents produced marked doserelated increases in the latencies of III and V and in the interpeak interval from III to V (Thornton et al., 1984) . It is interesting that these agents produce a profound depression of respiration and circulation which etomidate does not (Kugler, Doenicke and Laub, 1977) . The severity of the side effects of the inhalation agents probably results in part from the depression of brainstem structures, and it is possible that this is related to their effects on the brainstem components of the auditory evoked response.
The fact that anaesthesia with etomidate can be produced without an effect on a major part of the brainstem is an important observation. The idea that the state of anaesthesia results from a global action on the brain has been proposed (Halsey, 1974) and the reticular activating system is thought to be a particularly important site of anaesthetic action. The suggestion is that a decrease in activity in the brainstem causes a block in transmission to higher levels. However, it is clear from our results that, in the case of the auditory pathway at least, an anaesthetic can affect the cortex directly without producing a demonstrable effect on brainstem structures. This confirms our previous impression that changes in the brainstem and early cortical waves were not necessarily causally related. After withdrawal of halothane we saw almost complete recovery of Pa and Nb at a time when III and V had not recovered at all (Thornton et al., 1984) . Among the possible interpretations of this observation was that the subtle changes in the brainstem components were not the cause of the major changes in the early cortical part of the auditory evoked response. The lack of effect of etomidate on the brainstem waves supports this hypothesis, and the idea that the state of anaesthesia results from actions at a cortical level. This being the case, the effects of anaesthetics on the brainstem components can probably be regarded as side effects. The final serum concentration varied considerably between patients, in spite of their receiving the same amount of etomidate on a weight basis (1.5 mg kg" 1 ) over the 50-min infusion period. In one patient, etomidate was not detectable until after 35 min of infusion and the final serum concentration in this patient was 0.32 ^g ml" 1 . At the other extreme, in another patient, the final concentration was 1.72 (xg ml" 1 . This pronounced variability emphasizes the need for a feedback system for administering i.v. agents.
In conclusion, the waves Pa and Nb of the early cortical response showed dose-related changes with etomidate similar to those seen with halothane and enflurane and the magnitude of these changes was roughly in keeping with their anaesthetic potency. The brainstem response was unaffected by etomidate. The difference between etomidate and the inhalation agents in this respect is interesting in relation to the possible sites of action of these agents. It also means that the brainstem response would be unsuitable as a universal method for measuring depth of anaesthesia. For this purpose, we should concentrate on the early cortical section of the auditory evoked response.
